Boulder's BioLoomics raises $8.7 million in seed financing – Boulder Daily Camera
BioLoomics Inc., a Boulder-based life-sciences startup, has raised $8.7 million in seed financing.
Stay updated with breaking news from Array Biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioLoomics Inc., a Boulder-based life-sciences startup, has raised $8.7 million in seed financing.
SAN FRANCISCO--(BUSINESS WIRE)--Character Biosciences, a drug discovery and development company leveraging human genetics and medical imaging-based machine learning to target disease progression, today announced the appointment of Laura Carter, Ph.D. as Chief Scientific Officer. Dr. Carter brings a track record of m...
The efficacy of maintenance mirvetuximab soravtansine plus bevacizumab is being compared with bevacizumab alone in patients with folate receptor alpha–positive recurrent platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancers that did not progress on second-line triplet therapy in the phase 3 GLORIOSA study.
Pembrolizumab led to sustained improvements in recurrence-free survival and distant metastasis-free vs placebo as adjuvant therapy in patients with resected stage IIB or IIC melanoma
/PRNewswire/ -- Dr. Marvin H. Caruthers of the University of Colorado, Boulder, has won the inaugural Richard N. Merkin Prize in Biomedical Technology for...